Wednesday, 24 November 2010

Oseltamivir


Pronunciation: OH-sel-TAM-i-vir
Generic Name: Oseltamivir
Brand Name: Tamiflu


Oseltamivir is used for:

Treating influenza, including H1N1 influenza (swine flu), in patients 1 year of age and older who have had symptoms for no more than 2 days. It may also be used to prevent influenza in patients 1 year of age and older.


Oseltamivir is an antiviral. It works by stopping the flu virus from reproducing within the body.


Do NOT use Oseltamivir if:


  • you are allergic to any ingredient in Oseltamivir

  • you are going to have an intranasal live attenuated influenza vaccine (LAIV) within the next 2 days or you have had such a vaccine within the past 2 weeks

Contact your doctor or health care provider right away if any of these apply to you.



Before using Oseltamivir:


Some medical conditions may interact with Oseltamivir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have kidney problems, liver problems, heart problems, breathing problems, or mood or mental problems

Some MEDICINES MAY INTERACT with Oseltamivir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Intranasal live attenuated influenza vaccine (LAIV) because its effectiveness may be decreased by Oseltamivir

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oseltamivir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Oseltamivir:


Use Oseltamivir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Oseltamivir by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • If you are taking Oseltamivir to treat the flu, start taking it as soon as possible from when you begin noticing flu symptoms.

  • If you are using Oseltamivir to prevent the flu, start taking it as soon as possible, as directed by your doctor.

  • Take Oseltamivir on a regular schedule to get the most benefit from it.

  • To clear up your infection completely, take Oseltamivir for the full course of treatment. Keep taking it even if you feel better in a few days.

  • Continue to take Oseltamivir even if you feel well. Do not miss any doses.

  • If you miss a dose of Oseltamivir, take it as soon as possible. If it is within 2 hours of your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Oseltamivir.



Important safety information:


  • Oseltamivir is effective against influenza types A (including H1N1 influenza [swine flu]) and B.

  • Oseltamivir may cause dizziness or lightheadedness. These effects may be worse if you take it with alcohol or certain medicines. Use Oseltamivir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Oseltamivir may cause dizziness or lightheadedness; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Oseltamivir will not prevent you from spreading influenza to others.

  • Oseltamivir works only against influenza types A and B; it does not treat bacterial or other viral infections.

  • Patients with flu who take Oseltamivir may have an increased risk of confusion and unusual behavioral changes. The risk may be greater in children. Contact your doctor if you notice symptoms of confusion or any other unusual behavioral changes.

  • Tell your doctor or dentist that you take Oseltamivir before you receive any medical or dental care, emergency care, or surgery.

  • Tell your doctor that you take Oseltamivir before you receive any vaccines, including the intranasal live attenuated influenza vaccine (LAIV).

  • Oseltamivir is not a substitute for a flu vaccine. Continue to get an annual flu shot if your doctor has recommended it.

  • If your symptoms do not get better within a few days or if they get worse, check with your doctor.

  • Oseltamivir should be used with extreme caution in CHILDREN younger than 1 year old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oseltamivir while you are pregnant. It is not known if Oseltamivir is found in breast milk. If you are or will be breast-feeding while you use Oseltamivir, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Oseltamivir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; nausea; stomach pain; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal behavior; confusion; hallucinations; mood or mental changes; reddened, blistered, peeling, or swollen skin; seizures; severe or persistent nausea, vomiting, or diarrhea; symptoms of infection (eg, fever, chills, persistent sore throat).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Oseltamivir side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include nausea or vomiting.


Proper storage of Oseltamivir:

Store Oseltamivir at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oseltamivir out of the reach of children and away from pets.


General information:


  • If you have any questions about Oseltamivir, please talk with your doctor, pharmacist, or other health care provider.

  • Oseltamivir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is summary only. It does not contain all information about Oseltamivir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oseltamivir resources


  • Oseltamivir Side Effects (in more detail)
  • Oseltamivir Dosage
  • Oseltamivir Use in Pregnancy & Breastfeeding
  • Oseltamivir Drug Interactions
  • Oseltamivir Support Group
  • 20 Reviews for Oseltamivir - Add your own review/rating


  • oseltamivir Advanced Consumer (Micromedex) - Includes Dosage Information

  • Oseltamivir Phosphate Monograph (AHFS DI)

  • Tamiflu Prescribing Information (FDA)

  • Tamiflu Consumer Overview



Compare Oseltamivir with other medications


  • Avian Influenza
  • Influenza
  • Influenza Prophylaxis
  • Swine Flu

Tuesday, 16 November 2010

Cefuroxim Bipharma




Cefuroxim Bipharma may be available in the countries listed below.


Ingredient matches for Cefuroxim Bipharma



Cefuroxime

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Cefuroxim Bipharma in the following countries:


  • Netherlands

International Drug Name Search

Bicalutamide Sandoz




Bicalutamide Sandoz may be available in the countries listed below.


Ingredient matches for Bicalutamide Sandoz



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamide Sandoz in the following countries:


  • Estonia

  • France

  • Italy

  • Latvia

  • Lithuania

International Drug Name Search

Sunday, 14 November 2010

Danofloxacin Mesilate




Danofloxacin Mesilate may be available in the countries listed below.


Ingredient matches for Danofloxacin Mesilate



Danofloxacin

Danofloxacin Mesilate (BANM) is also known as Danofloxacin (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 11 November 2010

Bismuthate, Tripotassium Dicitrato-




ATC (Anatomical Therapeutic Chemical Classification)

A02BX05

CAS registry number (Chemical Abstracts Service)

0057644-54-9

Chemical Formula

C12-H10-Bi-K3-O14

Molecular Weight

704

Therapeutic Categories

Antacid

Treatment of peptic ulcer

Chemical Name

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(³+) potassium salt (2:1:3)

Foreign Name

  • Trikalium-bismuth(III)-dicitrat (German)

Generic Name

  • Bismuth subcitrate (IS)

Brand Names

  • Bicit HP
    Hemofarm, Serbia


  • Colipax
    Markos, Peru


  • Denol
    Astellas, South Africa; Elder, India


  • De-Nol
    Astellas, Italy; Astellas, Latvia; Astellas, Romania; Astellas, Russian Federation; Brocades, Singapore; Eczacibasi, Turkey; png Gerolymatos, Greece; Yamanouchi, Georgia


  • De-Noltab
    Astellas, United Kingdom; Astellas, Ireland


  • Gastrodenol
    Astellas, Spain


  • Lesux
    Zdravlje, Serbia


  • Pepsitol
    Idem Plus, Peru


  • Peptulan
    Farmasa, Brazil


  • Sucrato
    Armstrong, Mexico


  • Trymo
    Raptakos Brett, India

International Drug Name Search

Glossary

ISInofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 10 November 2010

Nilstat


Nilstat is a brand name of nystatin, approved by the FDA in the following formulation(s):


NILSTAT (nystatin - suspension; oral)



  • Manufacturer: GLENMARK GENERICS

    Approved Prior to Jan 1, 1982

    Strength(s): 100,000 UNITS/ML [RLD][AA]

Has a generic version of Nilstat been approved?


Yes. The following products are equivalent to Nilstat:


nystatin suspension; oral



  • Manufacturer: ACTAVIS MID ATLANTIC

    Approval date: July 14, 1982

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: FOUGERA

    Approval date: June 7, 1984

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: HI TECH PHARMA

    Approval date: February 28, 1994

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: TARO

    Approval date: February 29, 1988

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: VINTAGE PHARMS

    Approval date: June 28, 2005

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: VISTAPHARM

    Approval date: June 25, 1998

    Strength(s): 100,000 UNITS/ML [AA]


  • Manufacturer: VISTAPHARM

    Approval date: March 7, 2011

    Strength(s): 100,000 UNITS/ML [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nilstat. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Nilstat.

See also...

  • Nilstat Consumer Information (Cerner Multum)
  • Nilstat Drops Advanced Consumer Information (Micromedex)
  • Nystatin Consumer Information (Wolters Kluwer)
  • Nystatin Powder Consumer Information (Wolters Kluwer)
  • Nystatin Suspension Consumer Information (Wolters Kluwer)
  • Nystatin Consumer Information (Cerner Multum)
  • Mycostatin Suspension Advanced Consumer Information (Micromedex)
  • Nadostine Advanced Consumer Information (Micromedex)
  • Nadostine Sucrose-Free Advanced Consumer Information (Micromedex)
  • Nilstat Powder Advanced Consumer Information (Micromedex)
  • Nyaderm Advanced Consumer Information (Micromedex)
  • Pms-Nystatin Advanced Consumer Information (Micromedex)
  • Nystatin Advanced Consumer Information (Micromedex)

Thursday, 4 November 2010

Tadex




Tadex may be available in the countries listed below.


Ingredient matches for Tadex



Tamoxifen

Tamoxifen is reported as an ingredient of Tadex in the following countries:


  • Taiwan

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tadex in the following countries:


  • Finland

  • Turkey

International Drug Name Search

Co-Enalapril-Tchaikapharma




Co-Enalapril-Tchaikapharma may be available in the countries listed below.


Ingredient matches for Co-Enalapril-Tchaikapharma



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Co-Enalapril-Tchaikapharma in the following countries:


  • Bulgaria

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co-Enalapril-Tchaikapharma in the following countries:


  • Bulgaria

International Drug Name Search